The importance of hiring more nurses; addiction treatment and insurance; the golden age of biotech investing; and more

Opinion and perspective essays curated by First Opinion editor Patrick Skerrett ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by        This week's First Opinion essays covered how hiring more nurses can save lives, money, and retain existing nurses; the disconnect between effective addiction treatment and what insurers will pay for; the end of the golden era of biotech stocks; and more. You can read them all here. More nurses: The smart way to save lives, money — and nurses By Brigid Tonry AP Photo/John Minchillo If hospitals are truly committed to patient safety, they need to implement safe nurse-to-patient ratios in all of their units. Read More For addiction treatment, longer is better. But insurance companies usually cut it short By Nick Hayes Business Wire Longer engagement is a key to successful addiction treatment. Yet insurance companies tend to approve only short periods of treatment. Read More Is the golden age of biotech stocks over? By Nathan Vardi Adobe New political, regulatory, and structural obstacles may have put an end to the golden era of biotech stocks. Read More Sponsored Insight by STAT Madness Apply for STAT Madness! Has your institution innovated in ways worth celebrating? Submit your application to be considered for our bracket-style tournament to find the best innovations in science and medicine here. STAT+: Four types of bias in medical AI are running under the FDA's radar By Enes Hosgor and Oguz Akin Adobe Only a small minority of clinical AI products submitted to the FDA are accompanied by data covering potential sources of bias. Read More STAT+: Democratizing drug development will be a win for all By Vanessa Almendro MANDEL NGAN/AFP via Getty Images New tools are putting the drug development process within reach of a broader population of scientists — and even nonscientists. Read More A lesson from JPM: Too many digital front doors in health care lead to nowhere By Owen Tripp Photo illustration Alex Hogan/STAT, Adobe Many digital health applications lead to dead ends. Integration is the innovation that's needed now to solve that problem. Read More There are 4 gaps in global pandemic responses. The biggest is missing leadership By Jerome H. Kim Photo by SILVIO AVILA/AFP via Getty Images Gaps in the global response to the Covid-19 pandemic will handcuff responses to future epidemics and pandemics. Solutions exist for them. Read More Another Ebola outbreak, another missed opportunity for preparedness By Swati Gupta Hajarah Nalwadda/AP The world needs a stockpile of candidate vaccines that are available to be tested during outbreaks of Ebola, Nipah, and other diseases. Read More FTC's proposed ban on noncompete agreements could be a game changer for some physicians By Jeff Goldsmith Photo by Mario Tama/Getty Images A federal proposal to outlaw noncompete agreements would make it easier for physicians to switch from employment to private practice. Read More Sunday, January 15, 2023       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2023, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser